We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3808:HKEXSinotruk Hong Kong Ltd. Analysis

Data as of 2026-06-08 - not real-time

HK$42.66

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Sinotruk (HK) trades around HK$42.7, comfortably above its 20‑day SMA of 38.9 and the identified support at 35.5, while still below the 45.2 resistance level. Technical indicators are favorable: the RSI sits near 60, suggesting momentum without overbought pressure, and the MACD histogram is positive with a bullish signal line crossover. Volume is on an upward trend, reinforcing the price strength. The stock’s PE of roughly 14x is well under the industry average of 30x, and the forward PE of 11x signals attractive earnings growth expectations. A dividend yield of over 4% with a payout ratio under 50% points to a sustainable income stream backed by robust free cash flow. The balance sheet is solid, featuring ample cash reserves and a low debt‑to‑equity ratio, while ROE of about 15% reflects decent profitability. Valuation models (DCF) imply significant upside, and the market sentiment index shows “Extreme Greed,” indicating bullish investor appetite. Together, these fundamentals and technicals suggest the stock is positioned for continued appreciation, especially for investors seeking dividend income and value exposure in the Chinese heavy‑truck sector.
Given the high volatility (over 50% 30‑day) but very low systematic beta, price swings are likely driven more by company‑specific factors than broad market moves. The combination of strong cash generation, modest leverage, and attractive valuation makes Sinotruk a compelling candidate for both short‑term tactical plays and longer‑term strategic holding.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover with positive histogram
  • Increasing trading volume supporting price momentum
  • Price trading above 20‑day SMA and near support level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • PE ratio well below industry average indicating value
  • High dividend yield with sustainable payout
  • Strong free cash flow and low leverage

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value suggests substantial long‑run upside
  • Consistent earnings growth and solid ROE
  • Robust balance sheet and low systematic beta

Key Metrics & Analysis

Financial Health

Revenue Growth26.90%
Profit Margin6.41%
P/E Ratio14.5
ROE14.98%
ROA3.46%
Debt/Equity10.29
P/B Ratio2.3
Op. Cash FlowHK$7.6B
Free Cash FlowHK$12.0B
Industry P/E30.3

Technical Analysis

TrendNeutral
RSI59.7
SupportHK$35.54
ResistanceHK$45.24
MA 20HK$38.87
MA 50HK$40.36
MA 200HK$31.94
MACDBullish
VolumeIncreasing
Fear & Greed Index88.98

Valuation

Fair ValueHK$170.11
Target PriceHK$45.64
Upside/Downside6.99%
GradeUndervalued
TypeBlend
Dividend Yield4.23%

Risk Assessment

Beta0.01
Volatility54.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.